Which of the following will most likely happen when this anticancer drug is applied to a tumor that has a high level of EGFR? A) Tumor cells with active EGFR will increase and MAPK activity in the tumor will increase.
B) Tumor cells with active EGFR will decrease and MAPK activity in the tumor will increase.
C) Tumor cells with active EGFR will increase and MAPK activity in the tumor will decrease.
D) Tumor cells with active EGFR will decrease and MAPK activity in the tumor will decrease.